Tags: reviewsbreast cancer,early breast cancer,breast cancer treatment,early breast cancer treatment,CDK4/6 inhibitors,chemotherapy,patient selection,best candidates,treatments,therapiesLastPasspassword managersecurity
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. | Splicing Fungal Genes Help Cells Change Shape - 12 days ago | |
| 2 | Benj Edwards Ars Technica Reports on AI, ML. Explores AI's impact. Writes for Ars Technica. Raleigh, North Carolina | ||
| 3 | Allison Schiff AdExchanger Managing editor. Tweets rarely. New York City | IAB Tech Lab Has New Guidance On ‘ID-Less’ Solutions And It Wants Your Feedback - about 1 month ago | |
| 4 | Marty Swant Digiday Senior Reporter at Digiday. Brooklyn, NY | ||
| 5 | Kristen Monaco MedPage Today | Alternative Pathway Inhibition Makes Good in IgA Nephropathy - 2 months ago | |
| 6 | Laura Spitalniak Education Dive Education reporter at Higher Ed Dive. Washington, DC | How colleges can navigate a shifting test-optional landscape - 3 months ago | |
| 7 | Briley Kenney Digital Trends Senior Copywriter. Contributor @digitaltrends. Florida, United States | ||
| 8 | Matt Novak Gizmodo We come from the future | ||
| 9 | Jordan Fragen VentureBeat Adds context to gaming, esports data. Los Angeles, California | k-ID partners with codeveloper Rocket Science Group - 4 months ago | |
| 10 | Aisha Malik TechCrunch Senior Consumer News Writer at TechCrunch. |